Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Repeated childhood stroke and venous thrombosis: the risks

11.06.2007
Being over two-years-old, not being administered anti-coagulant drugs, and having a certain genetic mutation all increase the risks of repeated venous thrombosis (VT) in children, conclude authors of an Article published early Online and in the July edition of The Lancet Neurology.

Professor Ulrike Nowak-Göttl, Department of Paediatric Haematology and Oncology, University Hospital of Münster, Germany, and colleagues did a study of 396 children who had suffered a first cerebral venous thrombosis (CVT/stroke), and monitored them for an average of 36 months to determine the risk of a second cerebral or systemic venous thrombosis. The study is the largest and longest follow-up study of children with a first onset of stroke.

They found that 12 of the children died immediately, while 22 had recurrent VT, of which 13 were cerebral. Recurrent VT only occurred in children over two-years-old, and children who did not receive anti-coagulant drugs were 11 times for likely to have recurrent VT. Children suffering from venous occlusion (blocking of the veins to any blood flow) were over four times more likely to have recurrent VT, as were children with a genetic mutation already known to increase risk of VT.

The authors say: “Although cerebral venous thrombosis is associated with substantial mortality and morbidity, its causes in children have not been extensively investigated.”

Children older than two years who had a second VT did so at an average age of 13 years – the authors propose that this is because after the high risk first year of life, the next highest risk period of a child’s life relating to VT is puberty, probably due to hormonal changes and the down-regulation of the fibrinolytic system. This finding is backed by previous studies.

However the authors caution that continued use of anticoagulants in children has to be balanced against the risks of them suffering haemorrhages due to being physically active, and each case has to be considered individually. Where the risk of repeated VT is high, the benefit of anticoagulant therapy could clearly outweigh the risk of possible haemorrhage.

The authors conclude by calling for larger randomised studies into repeated VTs. They say: “Until data from such studies are available, the message of this follow-up study is clearly that administration of secondary anticoagulation prophylaxis should be considered on an individual patient basis in children with newly identified CVT in situations where the risk of VT is high.”

In an accompanying Comment, Dr Meredith Golomb, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, USA, says: “Recurrent venous thromboembolism after cerebral sinovenous thrombosis can be devastating.”

She then asks: “Which patients absolutely need to be on anticoagulation, and which ones can be safely weaned off? How can we tell the parents of an otherwise healthy five-year-old that he can never sled, perform gymnastics, or wrestle with his siblings? What doses of anticoagulation will keep the risk of recurrence and bleeding to a minimum?”

She concludes: “This paper provides some important answers; however, physicians, patients, and the patients’ families have many more questions.”

Tony Kirby | alfa
Further information:
http://www.thelancet.com

More articles from Health and Medicine:

nachricht Penn vet research identifies new target for taming Ebola
12.01.2017 | University of Pennsylvania

nachricht The strange double life of Dab2
10.01.2017 | University of Miami Miller School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

Im Focus: How to inflate a hardened concrete shell with a weight of 80 t

At TU Wien, an alternative for resource intensive formwork for the construction of concrete domes was developed. It is now used in a test dome for the Austrian Federal Railways Infrastructure (ÖBB Infrastruktur).

Concrete shells are efficient structures, but not very resource efficient. The formwork for the construction of concrete domes alone requires a high amount of...

Im Focus: Bacterial Pac Man molecule snaps at sugar

Many pathogens use certain sugar compounds from their host to help conceal themselves against the immune system. Scientists at the University of Bonn have now, in cooperation with researchers at the University of York in the United Kingdom, analyzed the dynamics of a bacterial molecule that is involved in this process. They demonstrate that the protein grabs onto the sugar molecule with a Pac Man-like chewing motion and holds it until it can be used. Their results could help design therapeutics that could make the protein poorer at grabbing and holding and hence compromise the pathogen in the host. The study has now been published in “Biophysical Journal”.

The cells of the mouth, nose and intestinal mucosa produce large quantities of a chemical called sialic acid. Many bacteria possess a special transport system...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

Nothing will happen without batteries making it happen!

05.01.2017 | Event News

 
Latest News

Water - as the underlying driver of the Earth’s carbon cycle

17.01.2017 | Earth Sciences

Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

17.01.2017 | Materials Sciences

Smart homes will “LISTEN” to your voice

17.01.2017 | Architecture and Construction

VideoLinks
B2B-VideoLinks
More VideoLinks >>>